Koers TaiGen Biopharmaceuticals Holdings Limited
Aandelen
4157
KYG866171005
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
15,4 TWD | -0,65% | -6,38% | +1,32% |
Omzet 2022 | 36,23 mln. 1,11 mln. 1,04 mln. | Omzet 2023 | 123 mln. 3,78 mln. 3,53 mln. | Marktkapitalisatie | 10,91 mld. 335 mln. 313 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -237 mln. -7,27 mln. -6,8 mln. | Nettowinst (verlies) 2023 | 137 mln. 4,21 mln. 3,93 mln. | EV/omzet 2022 | 294 x |
Nettoliquiditeiten 2022 | 860 mln. 26,4 mln. 24,66 mln. | Nettoliquiditeiten 2023 | 963 mln. 29,57 mln. 27,62 mln. | EV/omzet 2023 | 80,8 x |
K/w-verhouding 2022 |
-48,5
x | K/w-verhouding 2023 |
80
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 50% |
1 dag | -0,65% | ||
1 week | -6,38% | ||
Lopende maand | -0,32% | ||
1 maand | -0,32% | ||
3 maanden | +2,33% | ||
6 maanden | +3,01% | ||
Lopend jaar | +1,32% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Philip Huang
CEO | Chief Executive Officer | - | 17-12-18 |
Richard Lue
DFI | Director of Finance/CFO | - | 01-04-16 |
Ming-Chu Hsu
BRD | Director/Board Member | - | 01-04-01 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Shou-Chuan Ho
BRD | Director/Board Member | - | 29-04-13 |
Hong Jen Chang
BRD | Director/Board Member | 68 | 01-04-13 |
Sheng Fu Yu
BRD | Director/Board Member | 79 | 12-06-19 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.00% | 4 M€ | -4,41% | - | |
0.00% | 34 M€ | +2,14% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 15,4 | -0,65% | 2 047 624 |
25-04-24 | 15,5 | +0,32% | 1 956 406 |
24-04-24 | 15,45 | -0,32% | 3 644 589 |
23-04-24 | 15,5 | -0,64% | 3 939 570 |
22-04-24 | 15,6 | -5,17% | 13 097 220 |
slotkoers Taipei Exchange, 26 april 2024
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
+1,32% | 339 mln. | |
-2,31% | 103 mld. | |
+0,56% | 95,28 mld. | |
+1,69% | 22,15 mld. | |
-17,37% | 21,02 mld. | |
-9,30% | 18,15 mld. | |
-41,01% | 16,73 mld. | |
-14,85% | 16,05 mld. | |
+3,21% | 13,68 mld. | |
+33,54% | 12,17 mld. |